$3.05B
$719,000
0.0% of portfolio
20,209
Q2 2025
Reduced 8.05%
$2.26B
$126,000
0.0% of portfolio
1,978
Q1 2025
Added 13.09%
$354M
$60,000
0.0% of portfolio
1,689
Q2 2022
Reduced 23.88%
$487M
$3,000
0.0% of portfolio
116
Q2 2025
Added 176.19%
$0
$260,000
0.0% of portfolio
8,051
Q2 2025
Reduced 12.22%
$82.1B
$2.93 Million
0.0% of portfolio
157,570
Q2 2025
Reduced 15.75%
$0
$439,000
0.0% of portfolio
15,000
Q2 2018
Added 27.66%
$1.02B
$1,000
0.0% of portfolio
151
Q2 2025
Reduced 34.91%
$0
$396,000
0.0% of portfolio
18,288
Q3 2024
Reduced 12.38%
-
$0
0.0% of portfolio
-
Q2 2025
New
$332M
$238,000
0.0% of portfolio
5,719
Q2 2025
Added 26.41%
-
$0
0.0% of portfolio
-
Q2 2025
New
$6.21B
$91,000
0.0% of portfolio
3,041
Q2 2025
Reduced 25.74%
$2.63B
$1,000
0.0% of portfolio
240
Q2 2025
Reduced 90.2%
$12.1B
$2.57 Million
0.0% of portfolio
84,915
Q2 2025
Reduced 12.68%
$1.45B
$10,000
0.0% of portfolio
592
Q2 2025
Reduced 9.76%
$821M
$68,000
0.0% of portfolio
3,058
Q2 2025
Added 21.2%
$23.5B
$294,000
0.0% of portfolio
1,299
Q2 2025
Added 19.83%
$1.47B
$12,000
0.0% of portfolio
126
Q2 2025
Reduced 31.15%
$5.72B
$359,000
0.0% of portfolio
3,108
Q2 2025
Added 10.25%
$1.38B
$255,000
0.0% of portfolio
6,570
Q2 2025
Reduced 15.23%
$14.7B
$332,000
0.0% of portfolio
6,159
Q2 2025
Reduced 5.94%
$19.6B
$1.47 Million
0.0% of portfolio
19,980
Q2 2025
Added 4.44%
$1.19B
$135,000
0.0% of portfolio
5,396
Q1 2025
Reduced 74.33%
$261M
$55,000
0.0% of portfolio
20,114
Q2 2025
Reduced 8.99%
$171M
$0
0.0% of portfolio
12
Q1 2025
Reduced 86.67%
-
$0
0.0% of portfolio
-
Q1 2024
New
$639M
$4,000
0.0% of portfolio
617
Q2 2025
Added 71.87%
$337M
$100,000
0.0% of portfolio
20,025
Q2 2025
Reduced 9.78%
$9.75B
$768,000
0.0% of portfolio
35,828
Q2 2025
Reduced 39.51%
$5.4B
$89,000
0.0% of portfolio
1,931
Q2 2025
Reduced 55.17%
$6.91B
$2.11 Million
0.0% of portfolio
8,740
Q2 2025
Reduced 5.51%
$1.47B
$2,000
0.0% of portfolio
271
Q2 2025
New
$10.1B
$332,000
0.0% of portfolio
6,054
Q2 2025
Reduced 6.86%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.09B
$56,000
0.0% of portfolio
2,634
Q2 2025
Added 22.23%
$20.9B
$2.15 Million
0.0% of portfolio
17,109
Q2 2025
Reduced 34.06%
$25.5M
$6,000
0.0% of portfolio
1,575
Q2 2025
Reduced 9.01%
-
$0
0.0% of portfolio
-
Q1 2025
New
$23.5B
$203,000
0.0% of portfolio
1,913
Q2 2025
Reduced 15.17%
$0
$0
0.0% of portfolio
1,000
Q1 2023
New
$725M
$128,000
0.0% of portfolio
2,887
Q1 2025
Added 51.79%
$3.87B
$648,000
0.0% of portfolio
11,561
Q2 2025
Reduced 2.73%
$2.62B
$258,000
0.0% of portfolio
19,775
Q2 2025
Added 10.17%
$3.69B
$594,000
0.0% of portfolio
9,253
Q2 2025
Reduced 26.29%
$2.25B
$9,000
0.0% of portfolio
2,170
Q2 2025
Reduced 69.22%
$3.24B
$452,000
0.0% of portfolio
7,990
Q2 2025
Reduced 24.67%
$0
$122,000
0.0% of portfolio
4,750
Q3 2020
Reduced 29.63%
$0
$18,000
0.0% of portfolio
1,755
Q1 2025
New
$0
$4,000
0.0% of portfolio
463
Q2 2025
New